NEW YORK (GenomeWeb) – Natera reported today that its fourth quarter revenues rose 6 percent year over year thanks to a 56 percent increase in the number of accessioned tests.

For the three months ended Dec. 31, 2015, the company reported revenues of $52.9 million compared to $49.9 million in Q4 2014. The company beat analysts' consensus estimate of $45.3 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.